These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 21837801)
1. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children. Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique. Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014 [TBL] [Abstract][Full Text] [Related]
3. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748 [TBL] [Abstract][Full Text] [Related]
4. [Detection of respiratory syncytial virus in children with respiratory tract infections by nucleic acid amplification fluorogenic quantitative assay]. Tan ZT; Shi L; Lu GX; Xu W; Jia YP; Xing Y; Wu XL; Hu S; Ren Y; Wu LX Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):825-8. PubMed ID: 19849942 [TBL] [Abstract][Full Text] [Related]
5. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus. Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus (RSV) antibodies in different immunoglobulin classes in small children. Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A Acta Microbiol Pol; 1994; 43(3-4):359-68. PubMed ID: 7740986 [TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador. Colocho Zelaya EA; Pettersson CA; Forsgren M; Orvell C; Strannegard O Am J Trop Med Hyg; 1994 Nov; 51(5):577-84. PubMed ID: 7985749 [TBL] [Abstract][Full Text] [Related]
9. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934 [TBL] [Abstract][Full Text] [Related]
10. van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038 [TBL] [Abstract][Full Text] [Related]
13. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan. Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731 [TBL] [Abstract][Full Text] [Related]
14. Human metapneumovirus infection in hospital referred South African children. IJpma FF; Beekhuis D; Cotton MF; Pieper CH; Kimpen JL; van den Hoogen BG; van Doornum GJ; Osterhaus DM J Med Virol; 2004 Jul; 73(3):486-93. PubMed ID: 15170647 [TBL] [Abstract][Full Text] [Related]
15. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics. Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age. Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305 [TBL] [Abstract][Full Text] [Related]
17. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. Walsh EE; Falsey AR J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475 [TBL] [Abstract][Full Text] [Related]
18. Similar cytokine profiles in response to infection with respiratory syncytial virus type a and type B in the upper respiratory tract in infants. Bermejo-Martin JF; Tenorio A; Ortiz de Lejarazu R; Eiros JM; Matías V; Dominguez-Gil M; Pino M; Alonso A; Blanco-Quiros A; Arranz E; Ardura J Intervirology; 2008; 51(2):112-5. PubMed ID: 18493154 [TBL] [Abstract][Full Text] [Related]
19. Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants. Watt PJ; Zardis M; Lambden PR Clin Exp Immunol; 1986 Jun; 64(3):503-9. PubMed ID: 3791688 [TBL] [Abstract][Full Text] [Related]
20. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]